MyDrHank vs Ondra Health
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Readers who intend to pay for a full year up front and will do the arithmetic first — at the month-to-month rate this is one of the more expensive compounded sellers we cover.
- semaglutide
- $259/mo
- tirzepatide
- $349/mo
Before enrolling
Every advertised price is an annual-prepay minimum. The site's own code takes the cheapest rung of a four-term ladder and prints it as “From $X/mo”, so the $240/mo tirzepatide, $178/mo injectable semaglutide and $171/mo oral semaglutide it markets are what $2,883, $2,140 and $2,057 paid up front work out to per month — the month-to-month rates, $349, $259 and $249, are displayed nowhere, and the FAQ still calls the prepay figure a plan with “no contract”
Desk Score
Anyone who wants to know which pharmacy fills the vial before they pay, and is fine with a weekly injection.
- semaglutide
- $149/mo
- tirzepatide
- $219/mo
Before enrolling
Injectable only — no oral route
Our review of Ondra Health gives it 91/100 (A−), while our review of MyDrHank gives it 73/100 (C). The score breakdown shows where each provider does better.
Desk Score, dimension by dimension
Same six measured dimensions for both. The green bar marks the stronger score. See the methodology.
73/100
C
91/100
A−
The spec sheet
Check the billing terms before comparing the figures. Our guide to paying for GLP-1 care without insurance explains how medication charges, membership fees and prepaid terms affect what you owe.
| Field | MyDrHank | Ondra Health |
|---|---|---|
| Semaglutide | $259/moFull plan terms$259/mo month-to-month (compounded injectable; oral $249/mo; the injection's advertised $178/mo is a $2,140 annual prepay, and the $171/mo on its sign-up pages is the oral tablet's $2,057 annual prepay) | $149/moFull plan terms$149/mo month-to-month; $113/mo billed quarterly ($339); $108/mo on a 6-month plan ($649 up front); $96/mo on a 12-month plan ($1,149 up front); same price at every dose; compounded injectable |
| Tirzepatide | $349/moFull plan terms$349/mo month-to-month (compounded; the advertised $240/mo is a $2,883 annual prepay) | $219/moFull plan terms$219/mo month-to-month; $183/mo billed quarterly ($549); $167/mo on a 6-month plan ($999 up front); $142/mo on a 12-month plan ($1,699 up front); same price at every dose; compounded injectable |
| Coverage | 44 states (excludes Kansas, Louisiana, Mississippi, New Mexico, North Dakota, West Virginia) | All 50 states and Puerto Rico |
| Brand-name | Not confirmed here | Not confirmed here |
| Oral option | Oral option listed | Not confirmed here |
| Best for | Readers who intend to pay for a full year up front and will do the arithmetic first — at the month-to-month rate this is one of the more expensive compounded sellers we cover. | Anyone who wants to know which pharmacy fills the vial before they pay, and is fine with a weekly injection. |
| Desk Score | 73/100C | 91/100A− |
The verdict
Desk pick — Ondra HealthOndra Health has the higher Desk Score, but MyDrHank may be a better fit if it covers your state, offers the prescribed product or has billing terms that work better for you.
Readers who intend to pay for a full year up front and will do the arithmetic first — at the month-to-month rate this is one of the more expensive compounded sellers we cover.
Anyone who wants to know which pharmacy fills the vial before they pay, and is fine with a weekly injection.
CoreAge Rx leads the whole ranking at 94/100
Whichever of these two you lean toward, our #1-rated provider outscores them both. Both compounded injections with dose-independent advertised rates. The $79 and $129 monthly equivalents require a year paid in full; confirm the total charge and refund terms.
More head-to-heads
- CoreAge Rx vs MyDrHank
- CoreAge Rx vs Ondra Health
- MyDrHank vs Strut Health
- Ondra Health vs Sesame Care
- MyDrHank vs Tyde Wellness
- Ondra Health vs Vaylen
Or see the full comparison hub and the complete ranking.